Correction: Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study
Crossref DOI link: https://doi.org/10.1007/s10120-024-01519-0
Published Online: 2024-06-12
Published Print: 2024-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kodera, Yasuhiro
Yoshida, Kazuhiro
Kochi, Mitsugu
Sano, Takeshi
Ichikawa, Wataru
Kakeji, Yoshihiro
Sunakawa, Yu
Takeuchi, Masahiro
Fujii, Masashi
Text and Data Mining valid from 2024-06-12
Version of Record valid from 2024-06-12
Article History
First Online: 12 June 2024